Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry.

Local ablative therapy for PCa treatment is more commonly offered among older and comorbid patients. Future studies should investigate the uptake of these technologies in non-hospital-based settings and in light of recent changes in insurance coverage.